- Home
- TREE vs SGMO Comparison
TREE vs SGMO Comparison
Compare TREE & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TREE
- SGMO
- Stock Information
- Founded
- TREE 1996
- SGMO 1995
- Country
- TREE United States
- SGMO United States
- Employees
- TREE N/A
- SGMO N/A
- Industry
- TREE Finance: Consumer Services
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TREE Finance
- SGMO Health Care
- Exchange
- TREE Nasdaq
- SGMO Nasdaq
- Market Cap
- TREE 543.0M
- SGMO 488.2M
- IPO Year
- TREE N/A
- SGMO 2000
- Fundamental
- Price
- TREE $40.64
- SGMO $1.09
- Analyst Decision
- TREE Buy
- SGMO Buy
- Analyst Count
- TREE 8
- SGMO 5
- Target Price
- TREE $64.00
- SGMO $5.20
- AVG Volume (30 Days)
- TREE 228.1K
- SGMO 10.5M
- Earning Date
- TREE 02-25-2025
- SGMO 03-12-2025
- Dividend Yield
- TREE N/A
- SGMO N/A
- EPS Growth
- TREE N/A
- SGMO N/A
- EPS
- TREE N/A
- SGMO N/A
- Revenue
- TREE $773,050,000.00
- SGMO $52,291,000.00
- Revenue This Year
- TREE $32.88
- SGMO N/A
- Revenue Next Year
- TREE $16.82
- SGMO $5.97
- P/E Ratio
- TREE N/A
- SGMO N/A
- Revenue Growth
- TREE 4.44
- SGMO N/A
- 52 Week Low
- TREE $25.39
- SGMO $0.30
- 52 Week High
- TREE $62.49
- SGMO $3.18
- Technical
- Relative Strength Index (RSI)
- TREE 52.84
- SGMO 35.59
- Support Level
- TREE $35.50
- SGMO $1.00
- Resistance Level
- TREE $41.20
- SGMO $1.18
- Average True Range (ATR)
- TREE 1.65
- SGMO 0.16
- MACD
- TREE 0.43
- SGMO -0.06
- Stochastic Oscillator
- TREE 85.67
- SGMO 9.89
About TREE LendingTree Inc.
LendingTree Inc is a United States-based company that is principally engaged in operating an online loan marketplace. The company provides online tools and resources that can help consumers find loans or other credit-based offerings They need, including mortgage loans, reverse mortgage, home equity, personal loans, auto loans, credit cards, student loans, small business loans, and other related offerings. The company offers consumers direct access to a broad range of lenders. They have three reportable segments which are Home, Consumer, and Insurance. The company generates match fees by matching consumers with lenders, and closing fees from lenders on loans when a transaction is closed. The company operates business solely in the United States.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.